NCT01710839View on ClinicalTrials.gov

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Interventions
DRUG

0.5mg Ranibizumab

intravitreal injections

PROCEDURE

Targeted Pan Retinal Photocoagulation

Targeted Pan Retinal Photocoagulation based on wide field angiography

Trial Locations (3)

77030

Retina Consultants of Houston/The Medical Center, Houston

77384

Retina Consultants of Houston, The Woodlands

77494

Retina Consultants of Houston, Katy

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Charles C Wykoff, PhD, MD

OTHER

NCT01710839 - Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter